CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells-Reference-Cited by-同舟云学术

CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells

Published:2018-12-14 Issue:1 Volume:110 Page:256-268
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Uscanga‐Palomeque Ashanti Concepción¹,Calvillo‐Rodríguez Kenny Misael¹,Gómez‐Morales Luis¹,Lardé Eva²,Denèfle Thomas²,Caballero‐Hernández Diana¹,Merle‐Béral Hélène³,Susin Santos A.³,Karoyan Philippe²,Martínez‐Torres Ana Carolina¹^ORCID,Rodríguez‐Padilla Cristina¹

Affiliation:

1. College of Biology Science Laboratory of Immunology and Virology Autonomus University of Nuevo Leon San Nicolas de los Garza Mexico

2. CNRS Biomolecules Laboratory Superior Normal School PSL University Sorbonne University Paris France

3. INSERM UMRS 1138 Sorbonne University University of Paris Descartes Sorbonne Paris Cite Center of Reserch of Cordeliers Paris France

Funder

Universidad Autónoma de Nuevo León

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13885

Reference70 articles.

1. Immunogenic Cell Death in Cancer Therapy

2. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

3. The role of damage‐associated molecular patterns (DAMPs) in human diseases: part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine;Land WG;Sultan Qaboos Univ Med J,2015

4. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox

5. Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09

2. Immunopeptides: immunomodulatory strategies and prospects for ocular immunity applications;Frontiers in Immunology;2024-07-15

3. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions;Frontiers in Cell and Developmental Biology;2024-06-03

4. Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma;Translational Cancer Research;2024-06

5. Deregulation of New Cell Death Mechanisms in Leukemia;Cancers;2024-04-25